Here, mature dendritic cells present tumor-specific antigens to peripheral naive FoxP3+ Treg cells, which then proliferate in situ and are thereafter capable of suppressing the anti tumor immune response of CD8+ effector T-cells through heterogeneous mechanisms including IL-10 and TGF-ß [32], [48], [51], [54]. The gene discussed is IL10; the disease is neoplasm.